Cannabix Technologies Provides Development Update
June 1, 2015
Vancouver, British Columbia, June 1, 2015 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF), developer of a hand-held Cannabix marijuana breathalyzer for law enforcement and the workplace, is pleased to provide the following development update:
Cannabix has been using a methodical iterative product development process to develop its marijuana breathalyzer. Using this method, the product is developed in prototype stages with each stage used to advance the product to subsequent stages. Cannabix has moved the development of the Cannabix marijuana breathalyzer from a very early concept stage through the proof of concept stage and to the Alpha prototype stage.
The current iteration of the Alpha prototype is primarily used for testing purposes to help establish key features and define the direction of future component iterations by eliminating unnecessary features and design aspects early in the process. The Alpha version of the Cannabix breathalyzer utilizes spit separation technology to avoid contamination of THC breath samples collected for analysis. The Company continues to refine the sensitivity and modify certain components in its efforts to be able to achieve medical grade reproducibility of test results. To date, the Company has progressed well in testing with medical marijuana users and is working to advance the product to a Beta prototype stage as soon as developments permit. The Alpha prototype is not intended for third party testing.
The Company continues to define specifications required from suppliers to be incorporated into a Beta version of the Cannabix breathalyzer. Only a Beta version will be acceptable for third party testing to assess the operability and measurement precision of the device for use by law enforcement.
To date, the Company has advanced development of this ground breaking technology in an efficient and accountable manner. The Company continues to maintain its development transparency, reporting each milestone as it has been achieved.
Kal Malhi, President of Cannabix Technologies stated, “I am proud of the manner in which we have taken an academic concept on breath testing for THC to our current Alpha prototype stage. We have achieved this development in a very fiscally responsible manner and have been accountable to our shareholders along each step of the way. I, my partners, family members and colleagues continue to hold approximately 1/3rd of the equity in the Company. In addition, we have very loyal shareholders who have further supported us financially through exercise of warrants as we have achieved milestones. Cannabix is well funded to achieve its objectives and is progressing steadily and continues to engage some of the best minds in the field to develop this technology for law enforcement and the workplace.”
We seek Safe Harbor.
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.